市場調查報告書

心房纖維顫動設備的全球市場:2019年∼2025年

Global Atrial Fibrillation Devices Market 2019-2025

出版商 Orion Market Research Pvt Ltd 商品編碼 888707
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
心房纖維顫動設備的全球市場:2019年∼2025年 Global Atrial Fibrillation Devices Market 2019-2025
出版日期: 2019年11月12日內容資訊: 英文
簡介

本報告提供全球心房纖維顫動設備市場相關調查分析,市場概要,市場決策要素,市場區隔,競爭情形,各地區分析,主要企業等相關的系統性資訊。

目錄

第1章 報告概要

  • 調查方法與工具
  • 市場分析
    • 各市場區隔
    • 各地區
    • 各利害關係者

第2章 市場概要與考察

  • 報告的範圍
  • 分析師的考察、目前市場趨勢
    • 主要調查結果
    • 推薦事項
    • 結論
  • 規則與法規

第3章 競爭環境

  • 企業佔有率分析
  • 主要策略分析
  • 主要企業分析
    • Abbott Laboratories, Inc.
    • Johnson&Johnson Services,Inc.
    • Boston Scientific Corp.
    • Medtronic PLC
    • Siemens AG

第4章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 市場機會

第5章 市場區隔

  • 全球心房纖維顫動設備市場:各產品
    • 電生理學導管消融術
    • 電氣生理學診斷導管
    • 電生理學製圖及記錄系統
    • 心臟監測
    • 其他(左心房附屬器(LAA)及封閉設備)
  • 全球心房纖維顫動設備市場:各終端用戶
    • 醫院、診療所
    • 門診外科手術中心(ASC)

第6章 地區分析

  • 北美
    • 南北美洲
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他
  • 其他地區

第7章 企業概要

  • Abbott Laboratories Inc.
  • AblaCor Medical Corp.
  • AtriCure, Inc.
  • Biomerics, LLC
  • Biotronik, Inc.
  • Boston Scientific Corp.
  • CardioFocus, Inc.
  • CathVision ApS
  • General Electric Co.
  • Integer Holdings Corp.
  • Japan Lifeline Co., Ltd.
  • Johnson & Johnson (Biosense Webster, Inc.)
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Microport Scientific Corp.
  • Millar, Inc.
  • Molecular Devices, LLC
  • Rhythmlink International, LLC
  • Sanofi SA
  • Stryker Corp.
  • Transonic Systems, Inc.

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: OMR2020006

Atrial fibrillation is clinically the most prevalent disorder with a high impact on the quality of life and growing risk for mobility in men and women and hospitalization. The global atrial fibrillation devices market is expected to grow substantially at a CAGR of 13.7% over the forecast period. Factors augmenting the growth of the market include the rising prevalence of atrial fibrillation coupled with the significant incidences of cardiac arrhythmias and rising demand for minimally invasive procedures.

The global atrial fibrillation devices market is segmented on the basis of product type, end-use, and region. On the basis of product type, the market is sub-segmented into electrophysiology ablation catheters, electrophysiology diagnostic catheters, electrophysiology mapping and recording systems, cardiac monitors, and others. Based on the end-use, the market is divided into hospitals and ambulatory surgery centers (ASCs). Geographically, the market has been analyzed into North America, Europe, Asia-Pacific, and the Rest of the World. North America held the dominating position in the global atrial fibrillation devices market in 2018 and is further estimated to follow the same trend over the forecast period. This is due to the growing adoption of advanced technologies coupled with the well-developed healthcare infrastructure in the region. Moreover, Asia-Pacific is estimated to grow at the fastest growth rate over the forecast period.

Furthermore, the global atrial fibrillation devices market is influenced by the presence of several players including Abbott Laboratories Inc., Medtronic PLC, Boston Scientific Corp., Koninklijke Philips NV, Siemens AG, and many others. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players. For instance, In May 2019, Koninklijke Philips NV announced a collaboration with Medtronic PLC to further advance the treatment of paroxysmal atrial fibrillation, a common heart rhythm disorder. Through the agreement, Medtronic will facilitate sales of products on behalf of Philips to provide an innovative, integrated image guidance solution for cryoablation procedures. Additionally. Philips will bring the novel KODEX-EPD cardiac imaging and navigation system with cryoablation specific features to enable electrophysiologists to perform cryoablation procedures with reduced need for X-ray imaging into the market.

Research Methodology

The market study of the global atrial fibrillation devices market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for atrial fibrillation devices manufacturers, research organizations, medical device manufacturing companies, hospitals, ambulatory surgery centers, market research firms, government organizations, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:

1. Global Atrial Fibrillation Devices Market Research and Analysis by Product Type

2. Global Atrial Fibrillation Devices Market Research and Analysis by End-Use

The Report covers:

  • Comprehensive research methodology of the global atrial fibrillation devices market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global atrial fibrillation devices market.
  • Insights about market determinants which are stimulating the global atrial fibrillation devices market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Abbott Laboratories Inc.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Boston Scientific Corp.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Koninklijke Philips NV
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Siemens AG
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Medtronic PLC
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Atrial Fibrillation Devices Market by Product Type
    • 5.1.1. Electrophysiology Ablation Catheters
    • 5.1.2. Electrophysiology Diagnostic Catheters
    • 5.1.3. Electrophysiology Mapping and Recording Systems
    • 5.1.4. Cardiac Monitors
    • 5.1.5. Others (Intracardiac Echocardiography (ICE) Systems)
  • 5.2. Global Atrial Fibrillation Devices Market by End-Use
    • 5.2.1. Hospitals and Clinics
    • 5.2.2. Ambulatory Surgery Centers (ASCs)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. Japan
    • 6.3.3. India
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories Inc.
  • 7.2. Advanced Cardiac Therapeutics, Inc.
  • 7.3. AliveCor, Inc.
  • 7.4. AtriCure, Inc.
  • 7.5. AuriGen Medical
  • 7.6. BIOTRONIK SE & Co. KG
  • 7.7. Boston Scientific Corp.
  • 7.8. CardioFocus, Inc.
  • 7.9. CathRx Ltd.
  • 7.10. General Electric Co.
  • 7.11. Hansen Medical Inc.
  • 7.12. Japan Lifeline Co.
  • 7.13. Johnson and Johnson Services Inc. (Biosense Webster)
  • 7.14. Koninklijke Philips NV
  • 7.15. Medtronic PLC
  • 7.16. MicroPort Scientific Corp.
  • 7.17. Osypka AG
  • 7.18. Siemens AG
  • 7.19. Stereotaxis, Inc.
  • 7.20. Vanguard AG
  • 7.21. Verily Life Sciences LLC

List of Tables

1. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)

2. GLOBAL ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

3. GLOBAL ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

4. GLOBAL ELECTROPHYSIOLOGY MAPPING AND RECORDING SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

5. GLOBAL CARDIAC MONITORS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

6. GLOBAL OTHER ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

7. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2018-2025 ($ MILLION)

8. GLOBAL ATRIAL FIBRILLATION DEVICES IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

9. GLOBAL ATRIAL FIBRILLATION DEVICES IN ASC MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

10. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)

11. NORTH AMERICAN ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

12. NORTH AMERICAN ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)

13. NORTH AMERICAN ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2018-2025 ($ MILLION)

14. EUROPEAN ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

15. EUROPEAN ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)

16. EUROPEAN ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2018-2025 ($ MILLION)

17. ASIA-PACIFIC ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

18. ASIA-PACIFIC ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)

19. ASIA-PACIFIC ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2018-2025 ($ MILLION)

20. REST OF THE WORLD ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)

21. REST OF THE WORLD ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2018-2025 ($ MILLION)

List of Figures

1. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET SHARE BY PRODUCT TYPE, 2018 VS 2025 (%)

2. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET SHARE BY END-USE, 2018 VS 2025 (%)

3. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)

4. US ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

5. CANADA ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

6. UK ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

7. FRANCE ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

8. GERMANY ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

9. ITALY ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

10. SPAIN ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

11. ROE ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

12. CHINA ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

13. JAPAN ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

14. INDIA ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

15. REST OF ASIA-PACIFIC ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

16. REST OF THE WORLD ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)